Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
27
9
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
Identifiants
pubmed: 37635285
doi: 10.1097/TP.0000000000004769
pii: 00007890-202310000-00019
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2203-2215Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest
Références
Jesse MT, Jackson WE, Liapakis A, et al.; AST LDLT Consensus Conference Working Group. Living donor liver transplant candidate and donor selection and engagement: meeting report from the living donor liver transplant consensus conference [published online ahead of print, 2023 Mar 9]. Clin Transplant. 2023;37:e14954.
Rela M, Rammohan A. Why are there so many liver transplants from living donors in Asia and so few in Europe and the US? J Hepatol. 2021;75:975–980.
Ikegami T, Kim JM, Jung DH, et al. Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation. Korean J Transplant . 2019;33:65–73.
Kim KH, Kim SH, Cho HD. The short- and long-term outcomes in living-donor liver transplantation using small-for-size graft: a systematic review and meta-analysis. Transplant Rev (Orlando). 2023;37:100747.
Masuda Y, Yoshizawa K, Ohno Y, et al. Small-for-size syndrome in liver transplantation: definition, pathophysiology and management. HBPD INT. 2020;19:334–341.
Atkins D, Best D, Briss PA, et al.; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926.
Soin AS, Chaudhary RJ, Pahari H, et al. A worldwide survey of live liver donor selection policies at 24 centers with a combined experience of 19009 adult living donor liver transplants. Transplantation. 2019;103:e39–e47.
Kuramitsu K, Egawa H, Keeffe EB, et al. Impact of age older than 60 years in living donor liver transplantation. Transplantation. 2007;84:166–172.
Abdelfattah MR, Elsiesy H. Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis. Eur J Gastroenterol Hepatol. 2015;27:593–599.
Reichman TW, Sandroussi C, Azouz SM, et al. Living donor hepatectomy: the importance of the residual liver volume. Liver Transpl. 2011;17:1404–1411.
Hsieh CE, Lin KH, Hsu YL, et al. Clinical outcome of residual liver volume and hepatic steatosis after right-lobe living-donor hepatectomy. Ann Transplant. 2020;25:e919502.
Schmucker DL, Sanchez H. Liver regeneration and aging: a current perspective. Curr Gerontol Geriatr Res. 2011;2011:526379.
Yoshizumi T, Itoh S, Shimokawa M, et al. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol. 2021;74:372–379.
Ono Y, Kawachi S, Hayashida T, et al. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery. 2011;150:154–161.
Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg. 2018;267:1126–1133.
Yeow M, Pang NQ, Muthiah MD, et al. Impact of donor age on recipient morbidity and mortality after living donor liver transplantation. ANZ J Surg. 2022;92:1867–1872.
Macshut M, Kaido T, Yao S, et al. Older donor age is a risk factor for negative outcomes after adult living donor liver transplantation using small-for-size grafts. Liver Transpl. 2019;25:1524–1532.
Abdallah A, Salman AA, Sholkamy AA, et al. Study of factors affecting Small for Size Syndrome Post-Adult living donor liver transplantation. Asian J Surg. 2021;44:452–458.
Pomposelli JJ, Goodrich NP, Emond JC, et al. Patterns of early allograft dysfunction in adult live donor liver transplantation: the A2ALL experience. Transplantation. 2016;100:1490–1499.
Yoshizumi T, Taketomi A, Soejima Y, et al. Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation. Transpl Int. 2008;21:81–88.
Ikegami T, Yoshizumi T, Sakata K, et al. Left lobe living donor liver transplantation in adults: what is the safety limit? Liver Transpl. 2016;22:1666–1675.
Sanefuji K, Iguchi T, Ueda S, et al. New prediction factors of small-for-size syndrome in living donor adult liver transplantation for chronic liver disease. Transpl Int. 2010;23:350–357.
Yao S, Kaido T, Uozumi R, et al. Is portal venous pressure modulation still indicated for all recipients in living donor liver transplantation? Liver Transpl. 2018;24:1578–1588.
Tsang LLC, Chen CL, Huang TL, et al. Preoperative imaging evaluation of potential living liver donors: reasons for exclusion from donation in adult living donor liver transplantation. Transplant Proc. 2008;40:2460–2462.
Jackson WE, Kaplan A, Saben JL, et al. Practice patterns of the medical evaluation of living liver donors in the United States. Liver Transpl. 2023;29:164–171.
Müller MJ, Braun W, Enderle J, et al. Beyond BMI: conceptual issues related to overweight and obese patients. Obes Facts. 2016;9:193–205.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275–286.
Leitzmann MF, Moore SC, Koster A, et al. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One. 2011;6:e18582.
Zazai R, Wilms B, Ernst B, et al. Waist circumference and related anthropometric indices are associated with metabolic traits in severely obese subjects. Obes Surg. 2014;24:777–782.
Guler N, Yaprak O, Gunay Y, et al. Major complications of adult right lobe living liver donors. Hepatobiliary & Pancreatic Diseases International. 2015;14:150–156.
Ho CM, Huang YM, Hu RH, et al. Revisiting donor risk over two decades of single-center experience: more attention on the impact of overweight. Asian J Surg. 2019;42:172–179.
Knaak M, Goldaracena N, Doyle A, et al. Donor BMI >30 is not a contraindication for live liver donation. Am J Transplant. 2017;17:754–760.
Emamaullee J, Conrad C, Kim M, et al. Assessment of the global practice of living donor liver transplantation. Transpl Int. 2021;34:1914–1927.
Testa G, Nadalin S, Klair T, et al.; ERAS4OLT.org working group. Optimal surgical workup to ensure safe recovery of the donor after living liver donation - a systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36:e14641.
Jun MJ, Shim JH, Kim SY, et al. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation. Liver Transpl. 2014;20:437–445.
Kim B, Kim SY, Kim KW, et al. MRI in donor candidates for living donor liver transplant: technical and practical considerations. J Magn Reson Imaging. 2018;48:1453–1467.
Qi Q, Weinstock AK, Chupetlovska K, et al. Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation. Clin Transplant. 2021;35:e14339.
Vohra S, Goyal N, Gupta S. Preoperative CT evaluation of potential donors in living donor liver transplantation. Indian J Radiol Imaging. 2014;24:350–359.
Lim J, Han S, Lee D, et al. Identification of hepatic steatosis in living liver donors by machine learning models. Hepatol Commun. 2022;6:1689–1698.
Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001;7:409–414.
Yoon Y, Song G, Lee S, et al. Safe use of right lobe living donor livers with moderate steatosis in adult-to-adult living donor liver transplantation: a retrospective study. Transpl Int. 2021;34:872–881.
Tourky MS, Salman AA, Salman MA, et al. Intraoperative factors associated with early recipient death after adult-to-adult living donor liver transplant. Exp Clin Transplant. 2021;19:817–825.
Toshima T, Yoshizumi T, Shimagaki T, et al. Which is better to use “body weight” or “standard liver weight”, for predicting small-for-size graft syndrome after living donor liver transplantation? Ann Gastroenterol Surg. 2021;5:363–372.
Shoreem H, Gad EH, Soliman H, et al. Small for size syndrome difficult dilemma: lessons from 10 years single centre experience in living donor liver transplantation. World J Hepatol. 2017;9:930–944.
Bhangui P, Sah J, Choudhary N, et al. Safe use of right lobe live donor livers with up to 20% macrovesicular steatosis without compromising donor safety and recipient outcome. Transplantation. 2020;104:308–316.
Trakroo S, Bhardwaj N, Garg R, et al. Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: a systematic review and meta-analysis. World J Gastroenterol. 2021;27:3682–3692.
Chung JH, Ryu JH, Yang KH, et al. Efficacy and safety of weight reduction of the donor in hepatic steatosis for living donor liver transplantation. Ann Transplant. 2020;25:e923211.
Choudhary NS, Saraf N, Saigal S, et al. Rapid reversal of liver steatosis with life style modification in highly motivated liver donors. J Clin Exp Hepatol. 2015;5:123–126.
Gupta A, Pamecha V, Patil NS, et al. Lifestyle optimization leads to superior liver regeneration in live liver donors and decreases early allograft dysfunction in recipients: a randomized control trial. Ann Surg. [Epub ahead of print. March 13, 2023]. doi:10.1097/SLA.0000000000005836.
doi: 10.1097/SLA.0000000000005836
Halazun KJ, Przybyszewski EM, Griesemer AD, et al. Leaning to the left: increasing the donor pool by using the left lobe, outcomes of the largest single-center North American experience of left lobe adult-to-adult living donor liver transplantation. Ann Surg. 2016;264:448–456.
Jo HS, Yu YD, Choi YJ, et al. Left liver graft in adult-to-adult living donor liver transplantation with an optimal portal flow modulation strategy to overcome the small-for-size syndrome—a retrospective cohort study. Int J Surg. 2022;106:106953.
Wong TC, Fung JYY, Cui TYS, et al. The risk of going small: lowering grwr and overcoming small-for-size syndrome in adult living donor liver transplantation. Ann Surg. 2021;274:e1260–e1268.
Agarwal S, Goyal N, Nayeem M, et al. Living donor liver transplantation in patients weighing ≥100 kg: low graft weight and obesity do not impact outcomes. Liver Transpl. 2017;23:35–42.
Yaprak O, Guler N, Altaca G, et al. Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes? HPB (Oxford). 2012;14:476–482.
Braun HJ, Roberts JP. Current status of left lobe adult to adult living donor liver transplantation. Curr Opin Organ Transplant. 2021;26:139–145.
Kitajima T, Kaido T, Iida T, et al. Left lobe graft poses a potential risk of hepatic venous outflow obstruction in adult living donor liver transplantation. Liver Transpl. 2016;22:785–795.
Yagi S, Singhal A, Jung DH, et al. Living-donor liver transplantation: right versus left. Int J Surg. 2020;82:128–133.
Roll GR, Parekh JR, Parker WF, et al. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013;19:472–481.
Acuna SA, Zhang W, Yoon PD, et al. Right lobe versus left lobe living donor liver transplantation: a systematic review and meta-analysis of donor and recipient outcomes. Transplantation. 2022;106:2370–2378.
Agarwal S, Selvakumar N, Rajasekhar K, et al. Minimum absolute graft weight of 650 g predicts a good outcome in living donor liver transplant despite a graft recipient body weight ratio of less than 0.8. Clin Transplant. 2019;33:e13705.
Fujiki M, Hashimoto K, Quintini C, et al. Living donor liver transplantation with augmented venous outflow and splenectomy: a promised land for small left lobe grafts. Ann Surg. 2022;276:838–845.
Soubrane O, Eguchi S, Uemoto S, et al. Minimally invasive donor hepatectomy for adult living donor liver transplantation: an international, multi-institutional evaluation of safety, efficacy and early outcomes. Ann Surg. 2022;275:166–174.
Cherqui D, Ciria R, Kwon CHD, et al. Expert consensus guidelines on minimally invasive donor hepatectomy for living donor liver transplantation from innovation to implementation: a Joint Initiative from the International Laparoscopic Liver Society (ILLS) and the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA). Ann Surg. 2021;273:96–108.
Ziogas IA, Kakos CD, Moris DP, et al. Systematic review and meta-analysis of open versus laparoscopy-assisted versus pure laparoscopic versus robotic living donor hepatectomy. Liver Transpl. [Epub ahead of print. March 6, 2023]. doi:10.1097/LVT.0000000000000115
doi: 10.1097/LVT.0000000000000115
Broering DC, Elsheikh Y, Alnemary Y, et al. Robotic versus open right lobe donor hepatectomy for adult living donor liver transplantation: a propensity score-matched analysis. Liver Transpl. 2020;26:1455–1464.
Jeong JS, Wi W, Chung YJ, et al. Comparison of perioperative outcomes between pure laparoscopic surgery and open right hepatectomy in living donor hepatectomy: propensity score matching analysis. Sci Rep. 2020;10:5314.
Lee B, Choi Y, Han HS, et al. Comparison of pure laparoscopic and open living donor right hepatectomy after a learning curve. Clin Transplant. 2019;33:e13683.
Kim NR, Han DH, Choi GH, et al. Comparison of surgical outcomes and learning curve for robotic versus laparoscopic living donor hepatectomy: a retrospective cohort study. Int J Surg. 2022;108:107000.
Amma BSPT, Mathew JS, Varghese CT, et al. Open to robotic right donor hepatectomy: a tectonic shift in surgical technique. Clin Transplant. 2022;36:e14775.
Papoulas M, Hakeem AR, Heaton N, et al. Pure laparoscopic versus open donor hepatectomy for adult living donor liver transplantation—a systematic review and meta-analysis. J Minim Access Surg. 2022;18:1–11.
Yeow M, Soh S, Starkey G, et al. A systematic review and network meta-analysis of outcomes after open, mini-laparotomy, hybrid, totally laparoscopic, and robotic living donor right hepatectomy. Surgery. 2022;172:741–750.
Rammohan A, Rela M. Robotic donor hepatectomy: are we there yet? World J Gastrointest Surg. 2021;13:668–677.
Tang A, Ng CH, Phang PH, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs Non-lean NAFLD—a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:1750–1760.e12.
Ozturk NB, Muhammad H, Gurakar M, et al. Liver transplantation in developing countries. Hepatol Forum. 2022;3:103–107.
Shukla A, Vadeyar H, Rela M, et al. Liver transplantation: east versus west. J Clin Exp Hepatol. 2013;3:243–253.
Uchiyama H, Shirabe K, Kimura K, et al. Outcomes of adult-to-adult living donor liver transplantation in 321 recipients. Liver Transpl. 2016;22:305–315.
Gavriilidis P, Azoulay D. Graft inflow modulation in living donor liver transplantation with a small-for-size graft: a systematic review and meta-analysis. Chirurgia (Bucur). 2022;117:245–257.
Kusakabe J, Yagi S, Sasaki K, et al. Is 0.6% reasonable as the minimum requirement of the graft-to-recipient weight ratio regardless of lobe selection in adult living-donor liver transplantation? Transplantation. 2021;105:2007–2017.
Troisi RI, Berardi G, Tomassini F, et al. Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review. Transplant Rev (Orlando). 2017;31:127–135.
Wong TCL, Fung JYY, Cui TYS, et al. The risk of going small: lowering GRWR and overcoming small-for-size syndrome in adult living donor liver transplantation. Ann Surg. 2021;274:e1260–e1268.
Chok KSH, Chan ACY, Fung JYY, et al. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation. Hepatol Int. 2017;11:517–522.
Sethi P, Thillai M, Thankamonyamma BS, et al. Living donor liver transplantation using small-for-size grafts: does size really matter? J Clin Exp Hepatol. 2018;8:125–131.
Selzner M, Kashfi A, Cattral MS, et al. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl. 2009;15:1776–1782.
Alim A, Erdogan Y, Yuzer Y, et al. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation. Liver Transpl. 2016;22:1643–1648.
Marubashi S, Nagano H, Eguchi H, et al. Minimum graft size calculated from preoperative recipient status in living donor liver transplantation. Liver Transpl. 2016;22:599–606.
Chan SC, Lo CM, Ng KKC, et al. Alleviating the burden of small-for-size graft in right liver living donor liver transplantation through accumulation of experience. Am J Transplant. 2010;10:859–867.
Campsen J, Blei AT, Emond JC, et al.; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2008;14:1273–1280.
Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–1421.
Uemoto S, Inomata Y, Sakurai T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70:152–157.
Soejima Y, Shimada M, Suehiro T, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl. 2003;9:581–586.
Toshima T, Harada N, Itoh S, et al. Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan. Clin Transplant. 2022;36:e14739.
Xia L, Qiao ZY, Zhang ZJ, et al. Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: the TEA cohort to evaluate long-term post-transplant outcomes. EClinicalMedicine. 2022;49:101476.
Wang YC, Yong CC, Lin CC, et al. Excellent outcome in living donor liver transplantation: treating patients with acute-on-chronic liver failure. Liver Transpl. 2021;27:1633–1643.
Vargas PA, Khanmammadova N, Balci D, et al. Technical challenges in LDLT—overcoming small for size syndrome and venous outflow reconstruction. Transplant Rev (Orlando). 2023;37:100750.
Gruttadauria S, Pagano D, Liotta R, et al. Liver volume restoration and hepatic microarchitecture in small-for-size syndrome. Ann Transplant. 2015;20:381–389.
Wu H, Yan LN, Li B, et al. Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res. 2007;37:1044–1051.
Durairaj MS, Shaji Mathew J, Mallick S, et al. Middle hepatic vein reconstruction in adult living donor liver transplantation: a randomized clinical trial. Br J Surg. 2021;108:1426–1432.
Goja S, Kumar Yadav S, Singh Soin A. Readdressing the middle hepatic vein in right lobe liver donation: triangle of safety. Liver Transpl. 2018;24:1363–1376.
Hirata Y, Agarwal S, Verma S, et al. A feasible technique for middle hepatic vein reconstruction in right lobe liver transplantation: usage of autologous portal vein with bench recanalized umbilical vein graft. Liver Transpl. 2021;27:296–300.
Varghese CT, Bharathan VK, Gopalakrishnan U, et al. Randomized trial on extended versus modified right lobe grafts in living donor liver transplantation. Liver Transpl. 2018;24:888–896.
Wang LY, Lan X, Zhang H, et al. [Impact of non-middle hepatic vein reconstruction on the result of low graft-to-recipient weight ratio living donor liver transplantation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019;50:760–764.
Hong SY, Kim T, Kim M, et al. Strategy for selective middle hepatic vein reconstruction in living donor liver transplantation using right lobe graft: a retrospective observational study. Transplant Proc. 2021;53:2318–2328.
Raut V, Alikhanov R, Belghiti J, et al. Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT. Surg Today. 2014;44:1189–1196.
Kokudo N, Sugawara Y, Kaneko J, et al. Reconstruction of isolated caudate portal vein in left liver graft. Liver Transpl. 2004;10:1163–1165.
Saito Y, Imura S, Morine Y, et al. Regeneration of caudate lobe after living donor liver transplantation: comparison with a surrogate model of left lobe graft. J Med Invest. 2021;68:330–333.
Takeda K, Tanaka K, Kumamoto T, et al. Severe outflow block syndrome caused by compression by the swollen caudate lobe after living donor liver transplantation: report of a case. Surg Today. 2012;42:177–180.
Nakamura T, Nobori S, Harada S, et al. Single vs multiple arterial reconstructions in living donor liver transplant. Transplant Proc. 2022;54:399–402.
Puri Y, Palaniappan K, Rammohan A, et al. Anatomical basis for selective multiple arterial reconstructions in living donor liver transplantation. Langenbecks Arch Surg. 2021;406:1943–1949.
Elkomos BE, Abdelaal A. Do we need to use a stent in biliary reconstruction to decrease the incidence of biliary complications in liver transplantation? A systematic review and meta-analysis. J Gastrointest Surg. 2023;27:180–196.
Arikan T, Emek E, Bozkurt B, et al. Does multiple bile duct anastomosis in living donor liver transplantation affect the postoperative biliary complications? Transplant Proc. 2019;51:2473–2477.
Soin AS. Smoothing the path: reducing biliary complications, addressing small-for-size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients. Liver Transpl. 2012;18(Suppl 2):S20–S24.
Rammohan A, Rela M, Kim DS, et al.; ERAS4OLT.org Working Group. Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations. Clin Transplant. 2022;36:e14657.
Ikegami T, Onda S, Furukawa K, et al. Small-for-size graft, small-for-size syndrome and inflow modulation in living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2020;27:799–809.
Reddy MS, Kaliamoorthy I, Rajakumar A, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017;23:1007–1014.
Orue-Echebarria MI, Lozano P, Olmedilla L, et al. “Small-for-flow” syndrome: concept evolution. J Gastrointest Surg. 2020;24:1386–1391.
Ikegami T, Balci D, Jung DH, et al. Living donor liver transplantation in small-for-size setting. Int J Surg. 2020;82:134–137.
Reddy MS, Rela M. Portosystemic collaterals in living donor liver transplantation: what is all the fuss about? Liver Transpl. 2017;23:537–544.
Soin AS, Yadav SK, Saha SK, et al. Is portal inflow modulation always necessary for successful utilization of small volume living donor liver grafts? Liver Transpl. 2019;25:1811–1821.
Elshawy M, Toshima T, Asayama Y, et al. Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation. Surg Case Rep. 2020;6:164.
Lee CY, Lim WX, Chen CL, et al. Efficacy and safety of splenic artery embolization for intractable ascites using Amplatzer vascular plug versus coil after living donor liver transplantation. Diagn Interv Radiol. 2022;28:478–485.
Taniguchi M, Shimamura T, Todo S, et al. Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today. 2015;45:663–671.
Graham JA, Samstein B, Emond JC. Early graft dysfunction in living donor liver transplantation and the small for size syndrome. Curr Transplant Rep. 2014;1:43–52.
Osman AMA, Hosny AA, El-Shazli MA, et al. A portal pressure cut-off of 15 versus a cut-off of 20 for prevention of small-for-size syndrome in liver transplantation: a comparative study. Hepatol Res. 2017;47:293–302.
Hori T, Ogura Y, Yagi S, et al. How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? Noninvasive measurement of indocyanine green elimination rate. Surg Innov. 2014;21:43–51.
Ogura Y, Hori T, El Moghazy WM, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16:718–728.
Yagi S, Iida T, Hori T, et al. Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation. 2006;81:373–378.
Asencio JM, Vaquero J, Olmedilla L, et al. “Small-for-flow” syndrome: shifting the “size” paradigm. Med Hypotheses. 2013;80:573–577.
Kaido T, Mori A, Ogura Y, et al. Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. Transplant Proc. 2011;43:2391–2393.
Sainz-Barriga M, Scudeller L, Costa MG, et al. Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation. Liver Transpl. 2011;17:836–848.
Chan SC, Lo CM, Chok KSH, et al. Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:649–656.
Jiang SM, Zhou GW, Zhang R, et al. Role of splanchnic hemodynamics in liver regeneration after living donor liver transplantation. Liver Transpl. 2009;15:1043–1049.
Martell M, Coll M, Ezkurdia N, et al. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol. 2010;2:208–220.
Mukhtar A, Dabbous H. Modulation of splanchnic circulation: role in perioperative management of liver transplant patients. World J Gastroenterol. 2016;22:1582–1592.
Eguchi S, Yanaga K, Sugiyama N, et al. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl. 2003;9:547–551.
Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant. 2005;5:1397–1404.
Emond JC, Goodrich NP, Pomposelli JJ, et al. Hepatic hemodynamics and portal flow modulation: the A2ALL experience. Transplantation. 2017;101:2375–2384.
Yao H, Wang Y. Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension. Open Life Sci. 2020;15:981–987.
Sand L, Rizell M, Houltz E, et al. Effect of patient position and PEEP on hepatic, portal and central venous pressures during liver resection. Acta Anaesthesiol Scand. 2011;55:1106–1112.
Wang H, Ikegami T, Harada N, et al. Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation. Surg Today. 2015;45:979–985.
Vasavada B, Chen CL, Zakaria M. Using low graft/recipient’s body weight ratio graft with portal flow modulation an effective way to prevent small-for-size syndrome in living-donor liver transplant: a retrospective analysis. Exp Clin Transplant. 2014;12:437–442.
Troisi R, de Hemptinne B. Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl. 2003;9:S36–S41.
Govil S, Reddy MS, Rela M. Has “small-for-size” reached its “sell-by” date. Transplantation. 2016;100:e119.
Wu TJ, Dahiya D, Lee CS, et al. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl. 2011;17:1035–1045.
Chikamori F, Nishida S, Selvaggi G, et al. Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg. 2010;34:320–326.
Takahashi Y, Matsuura T, Yoshimaru K, et al. Liver graft-to-spleen volume ratio as a useful predictive factor of the early graft function in children and young adults transplanted for biliary atresia: a retrospective study. Transpl Int. 2018;31:620–628.
Yao S, Kaido T, Yagi S, et al. Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Am J Transplant. 2019;19:2783–2794.
Xiao F, Wei L, Qu W, et al. Liver graft-to-spleen volume ratio as a useful predictive factor of the outcomes in living donor liver transplantation: a retrospective study. Front Surg. 2022;9:855695.
Cheng YF, Huang TL, Chen TY, et al. Liver graft-to-recipient spleen size ratio as a novel predictor of portal hyperperfusion syndrome in living donor liver transplantation. Am J Transplant. 2006;6:2994–2999.
Gyoten K, Mizuno S, Kato H, et al. A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio. Transplantation. 2016;100:2138–2145.
Yoshizumi T, Mori M. Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today. 2020;50:21–29.
Moon DB, Lee SG, Hwang S, et al. Splenic devascularization can replace splenectomy during adult living donor liver transplantation—a historical cohort study. Transpl Int. 2019;32:535–545.
Troisi R, Hoste E, Van Langenhove P, et al. Modulation of liver graft hemodynamics by partial ablation of the splenic circuit: a way to increase hepatic artery flow? Transplant Proc. 2001;33:1445–1446.
Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237:429–436.
Kelly DM, Miller C. Understanding the splenic contribution to portal flow: the role of splenic artery ligation as inflow modification in living donor liver transplantation. Liver Transpl. 2006;12:1186–1188.
Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75:1313–1317.
Ou HY, Huang TL, Chen TY, et al. Early modulation of portal graft inflow in adult living donor liver transplant recipients with high portal inflow detected by intraoperative color Doppler ultrasound. Transplant Proc. 2010;42:876–878.
Sainz-Barriga M, Reyntjens K, Costa MG, et al. Prospective evaluation of intraoperative hemodynamics in liver transplantation with whole, partial and DCD grafts. Am J Transplant. 2010;10:1850–1860.
Ikegami T, Toshima T, Takeishi K, et al. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. J Am Coll Surg. 2009;208:e1–e4.
Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant. 2005;19:769–772.
Ito K, Akamatsu N, Ichida A, et al. Splenectomy is not indicated in living donor liver transplantation. Liver Transpl. 2016;22:1526–1535.
Kurata N, Ogura Y, Ogiso S, et al. Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2019;18:337–342.
Takeishi K, Yoshizumi T, Ikegami T, et al. Transgastric endoscopic lumen-apposing metal stents for intra-abdominal fluid collections after living donor liver transplantation. Liver Transpl. 2020;26:598–601.
Tsutsumi N, Tomikawa M, Akahoshi T, et al. Pancreatic fistula after laparoscopic splenectomy in patients with hypersplenism due to liver cirrhosis: effect of fibrin glue and polyglycolic acid felt on prophylaxis of postoperative complications. Am J Surg. 2016;212:882–888.
Neumann UP, Langrehr JM, Kaisers U, et al. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int. 2002;15:226–232.
Troisi R, Hesse UJ, Decruyenaere J, et al. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant. 1999;13:380–388.
Yoshizumi T, Taketomi A, Soejima Y, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int. 2008;21:833–842.
Athanasiou A, Moris D, Damaskos C, et al. Splenectomy is not indicated in living donor liver transplantation. Liver Transpl. 2017;23:561–562.
Oura T, Taniguchi M, Shimamura T, et al. Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good? Am J Transplant. 2008;8:250–252.
Botha JF, Langnas AN, Campos BD, et al. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010;16:649–657.
Yamada T, Tanaka K, Uryuhara K, et al. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant. 2008;8:847–853.
Choudhary NS, Saigal S, Saraf N, et al. Recurrent hepatic encephalopathy due to surgically created shunt during living donor liver transplantation. J Clin Exp Hepatol. 2021;11:397–399.
Huang J, Yan L, Chen Z, et al. Hemi-portocaval shunt: a simple salvage maneuver for small-for-size graft during living donor liver transplantation: a case report. Chin Med J (Engl). 2011;124:2231–2233.
Tanaka K, Ogura Y. “Small-for-size graft” and “small-for-size syndrome” in living donor liver transplantation. Yonsei Med J. 2004;45:1089–1094.
Trotter JF, Adam R, Lo CM, et al. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl. 2006;12:1485–1488.
Kawasaki T, Moriyasu F, Kimura T, et al. Changes in portal blood flow consequent to partial hepatectomy: Doppler estimation. Radiology. 1991;180:373–377.
Vijayashanker A, Chikkala BR, Ghimire R, et al. Do natural portosystemic shunts need to be compulsorily ligated in living donor liver transplantation? J Clin Exp Hepatol. 2022;12:29–36.
Cusumano C, Gussago S, Guerra M, et al. Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review. Hepatol Int. 2022;16:983–992.
Awad N, Horrow MM, Parsikia A, et al. Perioperative management of spontaneous splenorenal shunts in orthotopic liver transplant patients. Exp Clin Transplant. 2012;10:475–481.
Kim H, Yoon KC, Lee KW, et al. Tips and pitfalls in direct ligation of large spontaneous splenorenal shunt during liver transplantation. Liver Transpl. 2017;23:899–906.
Braun MM, Bar-Nathan N, Shaharabani E, et al. Postshunt hepatic encephalopathy in liver transplant recipients. Transplantation. 2009;87:734–739.
Margarit C, Lázaro JL, Charco R, et al. Liver transplantation in patients with splenorenal shunts: intraoperative flow measurements to indicate shunt occlusion. Liver Transpl Surg. 1999;5:35–39.
Moon DB, Lee SG, Ahn C, et al. Application of intraoperative cine-portogram to detect spontaneous portosystemic collaterals missed by intraoperative doppler exam in adult living donor liver transplantation. Liver Transpl. 2007;13:1279–1284.
Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015;15:17–38.